Institutional Ownership Eye Point Pharmaceuticals, Inc. (EYPT)
This table provides information about the institutional ownership of Eye Point Pharmaceuticals, Inc. (EYPT). We have compiled data on the 159 institutions that hold shares in the stock, with a total of 67.1 Million shares, which have been reported (via 13F filing form) to have a value of $916 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Cormorant Asset Management, LP
Boston, MA |
Aug 14, 2025 Q2 2025 |
8,325,000
shares
|
$118 Million
7.9% of portfolio
|
Q2 2024
Added 20.77%
|
|
|
Suvretta Capital Management, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
6,804,091
shares
|
$96.6 Million
2.2% of portfolio
|
Q1 2025
Added 0.31%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Aug 14, 2025 Q2 2025 |
6,800,000
shares
|
$96.5 Million
0.11% of portfolio
|
Q2 2025
Added 9.68%
|
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
Aug 13, 2025 Q2 2025 |
4,599,450
shares
|
$65.3 Million
0.09% of portfolio
|
Q2 2025
Added 12.58%
|
|
|
Franklin Resources Inc
San Mateo, CA |
Aug 12, 2025 Q2 2025 |
4,301,123
shares
|
$61 Million
0.01% of portfolio
|
Q2 2025
Added 3.64%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
3,802,646
shares
|
$54 Million
0.0% of portfolio
|
Q2 2025
Reduced 0.83%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
3,764,881
shares
|
$53.4 Million
0.0% of portfolio
|
Q2 2024
Added 35.07%
|
|
|
Tcg Crossover Management, LLC
Palo Alto, CA |
Aug 14, 2025 Q2 2025 |
3,572,335
shares
|
$50.7 Million
6.85% of portfolio
|
Q4 2024
Added 287.31%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2025 Q2 2025 |
2,344,210
shares
|
$33.3 Million
0.0% of portfolio
|
Q2 2025
Added 2.54%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
1,592,048
shares
|
$22.6 Million
0.0% of portfolio
|
Q2 2025
Reduced 0.06%
|
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
1,515,549
shares
|
$21.5 Million
0.0% of portfolio
|
Q2 2025
Reduced 4.87%
|
|
|
Patient Square Capital LP
Menlo Park, CA |
Aug 11, 2025 Q2 2025 |
1,352,837
shares
|
$19.2 Million
4.59% of portfolio
|
Q2 2025
Reduced 8.71%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
1,280,692
shares
|
$18.2 Million
0.0% of portfolio
|
Q2 2025
Reduced 16.38%
|
|
|
Essex Woodlands Management, Inc.
The Woodlands, TX |
Aug 07, 2025 Q2 2025 |
1,169,857
shares
|
$16.6 Million
3.95% of portfolio
|
Q4 2024
Reduced 24.6%
|
|
|
5 Am Venture Management, LLC
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
1,050,000
shares
|
$14.9 Million
6.63% of portfolio
|
Q3 2024
Added 2000.0%
|
|
|
Abrdn PLC
|
Jul 24, 2025 Q2 2025 |
1,031,201
shares
|
$14.6 Million
0.02% of portfolio
|
Q2 2025
Added 346.9%
|
|
|
Bank Of America Corp
Charlotte, NC |
Aug 14, 2025 Q2 2025 |
814,153
shares
|
$11.6 Million
0.0% of portfolio
|
Q2 2025
Added 8.52%
|
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
782,642
shares
|
$11.1 Million
0.0% of portfolio
|
Q2 2025
Reduced 9.43%
|
|
|
Hsbc Holdings PLC
London, X0 |
Aug 13, 2025 Q2 2025 |
631,074
shares
|
$8.95 Million
0.0% of portfolio
|
Q2 2025
Added 0.95%
|
|
|
Nantahala Capital Management, LLC
New Canaan, CT |
Aug 14, 2025 Q2 2025 |
593,091
shares
|
$8.42 Million
0.24% of portfolio
|
Q1 2025
Reduced 1.15%
|
|
|
Blue Owl Capital Holdings LP
New York, NY |
Aug 11, 2025 Q2 2025 |
562,594
shares
|
$7.98 Million
2.87% of portfolio
|
Q2 2025
Reduced 29.46%
|
|
|
Principia Wealth Advisory, LLC
Dallas, TX |
Aug 14, 2025 Q2 2025 |
533,778
shares
|
$7.57 Million
4.25% of portfolio
|
Q1 2025
Added 97.42%
|
|
|
Northern Trust Corp
Chicago, IL |
Aug 13, 2025 Q2 2025 |
515,613
shares
|
$7.32 Million
0.0% of portfolio
|
Q2 2025
Reduced 18.14%
|
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Aug 12, 2025 Q2 2025 |
512,113
shares
|
$7.27 Million
0.0% of portfolio
|
Q2 2025
Added 43.27%
|
|
|
Woodline Partners LP
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
500,335
shares
|
$7.1 Million
0.03% of portfolio
|
Q1 2025
Reduced 0.28%
|